Betametazon, sodium diclofenac, hydroxocolamine
Acute inflammatory diseases of the musculoskeletal system. Increased rheumatism, inflammatory mono- and polyneuropathy.
Drug effects: The common element of the mechanism of action of the NPBC is the suppression of the synthesis of prostaglandins from peanut acid by inhibiting the enzyme cyclooxygenase. As a result, diclofenac inhibits cyclooxygenase isoforms now known as (COH1 and COH2). The analgesic effect is associated with the lowering of the mediators of the nociceptive conductive path. Betametazone is a steroid anti-inflammatory agent. Hydroxocoabalamine (Vitamin B12) acts as a coenzyme in several metabolic processes, including fat and carbohydrate metabolism and protein synthesis. It is necessary for cell growth, cell replication, blood flow and synthesis of nucleoproteins and myelins, largely due to its effects of methionine metabolism, folic acid and malonic acid.
Composition: Each vial contains: Betametazon (in the form of betametazon phosphate) 2 mg. Sodium diclofenac 75 mg Hydroxycobalamin 10 mg
Form of production: Injection Solution 3 ml N3, N6 (ampoules)